Renalase is an α-NAD(P)H oxidase/anomerase

被引：0
|
作者：
机构：
[1] Beaupre, Brett A.
[2] Carmichael, Brenton R.
[3] Hoag, Matthew R.
[4] Shah, Dhara D.
[5] Moran, Graham R.
来源：
Moran, G.R. (moran@uwm.edu) | 1600年 / American Chemical Society卷 / 135期
关键词：
Renalase is a protein hormone secreted into the blood by the kidney that is reported to lower blood pressure and slow heart rate. Since its discovery in 2005; renalase has been the subject of conjecture pertaining to its catalytic function. While it has been widely reported that renalase is the third monoamine oxidase (monoamine oxidase C) that oxidizes circulating catecholamines such as epinephrine; there has been no convincing demonstration of this catalysis in vitro. Renalase is a flavoprotein whose structural topology is similar to known oxidases; lysine demethylases; and monooxygenases; but its active site bears no resemblance to that of any known flavoprotein. We have identified the catalytic activity of renalase as an α-NAD(P)H oxidase/anomerase; whereby low equilibrium concentrations of the α-anomer of NADPH and NADH initiate rapid reduction of the renalase flavin cofactor. The reduced cofactor then reacts with dioxygen to form hydrogen peroxide and releases nicotinamide dinucleotide product in the β-form. These processes yield an apparent turnover number (0.5 s-1 in atmospheric dioxygen) that is at least 2 orders of magnitude more rapid than any reported activity with catechol neurotransmitters. This highly novel activity is the first demonstration of a role for naturally occurring α-NAD(P)H anomers in mammalian physiology and the first report of a flavoprotein catalyzing an epimerization reaction. © 2013 American Chemical Society;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Journal article (JA)
引用
收藏
相关论文
共 50 条
  • [31] PKC activates NAD(P)H oxidase in human failing heart
    Gupte, S
    Marks, B
    Zias, E
    Sarabu, M
    Wolin, M
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2004, 37 (01) : 273 - 273
  • [32] Expression of the NAD(P)H oxidase subunits in human coronary arteries
    Sorescu, D
    Weiss, D
    Lassègue, B
    Szöcs, K
    Vega, JD
    Taylor, WR
    Griendling, KK
    CIRCULATION, 2001, 104 (17) : 41 - 41
  • [33] Role of NAD(P)H oxidase and its regulation in chronic hypertension
    Iwai, Masaru
    Mogi, Masaki
    Horiuchi, Masatsugu
    HYPERTENSION RESEARCH, 2006, 29 (10) : 743 - 744
  • [34] Metformin induces suppression of NAD(P)H oxidase activity in podocytes
    Piwkowska, Agnieszka
    Rogacka, Dorota
    Jankowski, Maciej
    Dominiczak, Marek Henryk
    Stepinski, Jan Kazimierz
    Angielski, Stefan
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 393 (02) : 268 - 273
  • [35] Inhibition of NAD(P)H oxidase activity improves endothelial function
    Hamilton, CA
    Brosnan, MJ
    Dominiczak, AF
    HYPERTENSION, 2001, 38 (04) : 964 - 964
  • [36] Role of NAD(P)H Oxidase and Its Regulation in Chronic Hypertension
    Masaru Iwai
    Masaki Mogi
    Masatsugu Horiuchi
    Hypertension Research, 2006, 29 : 743 - 744
  • [37] Oxidative stress in arterial hypertension -: Role of NAD(P)H oxidase
    Zalba, G
    José, GS
    Moreno, MU
    Fortuño, MA
    Fortuño, A
    Beaumont, FJ
    Díez, J
    HYPERTENSION, 2001, 38 (06) : 1395 - 1399
  • [38] NAD(P)H oxidase: where there's smoke, there's fire
    Stokes, Karen Y.
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2007, 292 (01): : H119 - H120
  • [39] Up-stream regulation of endothelial NAD(P)H oxidase
    Krötz, F
    Sohn, HY
    JOURNAL OF VASCULAR RESEARCH, 2004, 41 (01) : 98 - 98
  • [40] The role of a yeast NAD(P)H-oxidase in aging and apoptosis
    Rinnerthaler, M.
    Heeren, G.
    Laun, P.
    Koessler, S.
    Rid, R.
    Klinger, H.
    Weinberger, M.
    Burhans, W. C.
    Breitenbach, M.
    FREE RADICAL RESEARCH, 2008, 42 : S99 - S99
12345